REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 188 filers reported holding REGENXBIO INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $211,899 | +0.4% | 9,343 | +72.4% | 0.00% | +100.0% |
| Q2 2021 | $211,000 | +3.4% | 5,419 | -9.2% | 0.00% | 0.0% |
| Q1 2021 | $204,000 | -61.1% | 5,966 | -48.5% | 0.00% | -66.7% |
| Q4 2020 | $525,000 | -65.8% | 11,576 | -73.2% | 0.00% | -75.0% |
| Q3 2019 | $1,535,000 | -27.9% | 43,125 | +4.1% | 0.01% | -29.4% |
| Q2 2019 | $2,129,000 | -16.7% | 41,445 | -7.1% | 0.02% | -19.0% |
| Q1 2019 | $2,556,000 | +43.5% | 44,595 | +5.0% | 0.02% | +40.0% |
| Q4 2018 | $1,781,000 | – | 42,456 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |